Healthgen Obtains CMMM Level 3 Certification

On August 11, 2026,Wuhan Healthgen Biotechnology CO.,LTD. officially obtained the “Certification of Compliance with the Intelligent Manufacturing Capability Maturity Model” (Certificate Number: CMMM-027-2761-2026-2162), with an assessment level of Level 3.

This certification is based on the national standards GB/T 39116-2020 “Intelligent Manufacturing Capability Maturity Model” and GB/T 39117-2020 “Evaluation Method for Intelligent Manufacturing Capability”. It undergoes a rigorous assessment covering the “Production of Recombinant Human Albumin Injection (Rice)”, and the assessment location is at No. 268, Shen Dun 5th Road, Donghu New Technology Zone, Wuhan City, Hubei Province.

What is the CMMM Level 3?

The third maturity level—termed the Integration Level—of intelligent manufacturing capability signifies that the enterprise has established cross-departmental and cross-system data interoperability and business collaboration, implemented a comprehensive intelligent manufacturing system, and demonstrated the capacity to sustain efficient, stable, and fully traceable large-scale production. This level reflects not only advanced technical infrastructure but also a holistic enhancement in management processes, quality assurance systems, and digital operational capabilities.

The intelligent practice of He Yuan Biotechnology

As a leading biopharmaceutical enterprise in China, Healthgen Biotech has always been committed to driving high-quality development through technological innovation. In May 2026, “The Digitalized, Process-Controlled, Intelligent Factory for the Full Process of Recombinant Albumin from Plant Sources” of Healthgen Biotech was awarded the “Advanced Level Intelligent Factory of Hubei Province in 2026” by the Hubei Provincial Department of Economy and Information Technology. This latest success story saw it successfully pass the CMMM (Capability Maturity Model Integration) Level 3 assessment for intelligent manufacturing capabilities. These two significant recognitions fully demonstrate the company’s high-level recognition for its integrated model of “Rice Expression and Purification Platform + Intelligent Production”, and also mark that the company is at the forefront in the field of intelligent manufacturing in the biopharmaceutical industry.

Future expectations

The company will take this as an opportunity to continuously optimize its intelligent manufacturing system, deepen data-driven decision-making, enhance its intelligent manufacturing capabilities, and contribute more “He Yuan wisdom” to ensuring drug safety, improving production efficiency, and promoting the green transformation of the industry.

Regarding the CMMM certification

CMMM (China Manufacturing Maturity Model) is a national-level intelligent manufacturing assessment system led by the China Electronics Standardization Research Institute. It is the authoritative standard for assessing intelligent manufacturing capabilities in China and is widely used for diagnosing and enhancing the intelligent level of manufacturing enterprises.